HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Olay

This article was originally published in The Rose Sheet

Executive Summary

Daily Facial Cleansing Cloths achieve 13 value share five months after launch, driving Olay from sixth spot to top-selling facial cleansing brand, P&G CFO Clayton Daley announces during Oct. 31 fiscal fourth quarter investor conference call. Beauty care sales grew 2% to $1.87 bil. for the quarter (ended Sept. 30), including 3% unfavorable exchange impact over year-ago period. Earnings for P&G leaped 19% to $267 mil., due to improved pricing, lower taxes and comparison to weak year-ago period. Net sales flat at $9.97 bil., while income grew 4% to $1.16 bil., excluding Organization 2005 charges

Latest Headlines
See All
UsernamePublicRestriction

Register

RS008632

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel